More politicking over FDA pick

Helen Palmer Sep 18, 2006
HTML EMBED:
COPY

More politicking over FDA pick

Helen Palmer Sep 18, 2006
HTML EMBED:
COPY

TEXT OF STORY

BOB MOON: President Bush’s nominee to head the Food and Drug Administration may be facing a big hurdle. Approval of the appointment might be blocked by members of Bush’s own party. Helen Palmer has more.


HELEN PALMER: This time a couple of GOP senators plan to derail von Eschenbach until their demands are met.

Louisiana’s David Vitter wants prescription drug imports legalized, and South Carolina Senator Jim DeMint insists FDA pull abortion pill RU 486 off the market.

Observers say overt use of the FDA Commissioner as a political football has escalated.

The Agency’s had a confirmed leader for only 18 months since the Bush Administration took office in 2001. Consumer advocates say the lack of consistent leadership puts Americans’ health at risk. A recent survey showed half of the FDA’s own scientists agree.

The FDA regulates products worth a quarter of the US economy, or nearly $3 trillion.

In Boston, I’m Helen Palmer for Marketplace.

We’re here to help you navigate this changed world and economy.

Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.

In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.

Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.